13 companies

AddLife

Market Cap: SEK 22.5b

Provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries.

ALIF B

SEK 184.40

7D

3.6%

1Y

61.2%

Bonesupport Holding

Market Cap: SEK 16.7b

An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.

New

BONEX

SEK 254.20

7D

-3.6%

1Y

-0.08%

BioGaia

Market Cap: SEK 10.1b

A healthcare company, provides probiotic products worldwide.

BIOG B

SEK 99.05

7D

-2.5%

1Y

-22.5%

Swedencare

Market Cap: SEK 6.4b

Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.

SECARE

SEK 40.00

7D

5.5%

1Y

-32.4%

Devyser Diagnostics

Market Cap: SEK 1.7b

Engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.

DVYSR

SEK 105.20

7D

5.2%

1Y

0.7%

Enzymatica

Market Cap: SEK 728.2m

A life science company, develops and sells products that treat and alleviate infections and symptoms in the upper respiratory tract.

ENZY

SEK 3.00

7D

-2.6%

1Y

-5.1%

Orexo

Market Cap: SEK 501.0m

A specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, the United Kingdom, and internationally.

ORX

SEK 14.52

7D

-6.2%

1Y

-27.4%

Promimic

Market Cap: SEK 358.0m

Manufactures, markets, and sells biomaterials for improved osseointegration for orthopedic and dental implants markets.

New

PRO

SEK 18.95

7D

6.8%

1Y

-41.3%

Mendus

Market Cap: SEK 275.0m

A biopharmaceutical company, develops immunotherapies for the treatment of tumor recurrence and established tumors.

IMMU

SEK 5.28

7D

2.7%

1Y

-47.9%

SenzaGen

Market Cap: SEK 154.0m

Provides non-animal tests for assessing a substance’s allergenicity.

New

SENZA

SEK 5.22

7D

0.4%

1Y

-39.7%

Biovica International

Market Cap: SEK 74.7m

A biotech company, develops and commercializes novel blood-based biomarker assays that enhance the monitoring and predicting of cancer therapies in the United States of America.

BIOVIC B

SEK 0.76

7D

0.3%

1Y

-68.2%

OncoZenge

Market Cap: SEK 62.8m

A pharmaceutical company, engages in the development of treatment for pain relief in patients suffering from oral pain caused by radiation therapy and chemotherapy for cancer in Sweden.

ONCOZ

SEK 5.36

7D

4.1%

1Y

54.9%

PharmaLundensis

Market Cap: SEK 15.3m

PharmaLundensis AB operates as a pharmaceutical company.

PHAL

SEK 0.36

7D

0%

1Y

-44.6%